These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 18430121

  • 1. The use of positron-emission tomography in the diagnosis of tumour phenotype.
    Divgi C.
    BJU Int; 2008 Jun; 101 Suppl 4():36-8. PubMed ID: 18430121
    [No Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.
    Pantuck AJ, Klatte T, Seligson D, Atkins M, Belldegrun A.
    J Clin Oncol; 2008 Jun 20; 26(18):3105-7; author reply 3107-9. PubMed ID: 18565906
    [No Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase IX: historical and future perspectives.
    Oosterwijk E.
    BJU Int; 2008 Jun 20; 101 Suppl 4():2-7. PubMed ID: 18430115
    [No Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia.
    Pastorekova S, Ratcliffe PJ, Pastorek J.
    BJU Int; 2008 Jun 20; 101 Suppl 4():8-15. PubMed ID: 18430116
    [No Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
    Brouwers AH, Mulders PF, Oyen WJ.
    J Clin Oncol; 2008 Aug 01; 26(22):3808-9; author reply 3811-2. PubMed ID: 18669472
    [No Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
    Signoretti S, Regan M, Atkins M.
    BJU Int; 2008 Jun 01; 101 Suppl 4():31-5. PubMed ID: 18430120
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
    Giménez-Bachs JM, Salinas-Sánchez AS, Serrano-Oviedo L, Nam-Cha SH, Rubio-Del Campo A, Sánchez-Prieto R.
    Scand J Urol Nephrol; 2012 Oct 01; 46(5):358-64. PubMed ID: 22571179
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.
    Pickering LM, Larkin J.
    Nat Rev Urol; 2015 Jun 01; 12(6):309-10. PubMed ID: 26032554
    [No Abstract] [Full Text] [Related]

  • 12. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology.
    Lin XY, Zhang H, Tang N, Zhang XP, Zhang W, Wang EH, Han YC.
    Histopathology; 2015 Apr 01; 66(5):685-94. PubMed ID: 25431204
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.
    Skapa P, Hyrsl L, Zavada J, Soukup J, Zamecnik J.
    J Clin Oncol; 2008 Aug 01; 26(22):3809-11; author reply 3811-2. PubMed ID: 18669473
    [No Abstract] [Full Text] [Related]

  • 14. [Comment to "Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression"].
    Salinas AS.
    Actas Urol Esp; 2011 Feb 01; 35(2):87-8. PubMed ID: 21288602
    [No Abstract] [Full Text] [Related]

  • 15. In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer.
    Brouwers AH, Boerman OC, Oyen WJ.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8886; author reply 8886. PubMed ID: 16361579
    [No Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.
    Clin Cancer Res; 2003 Feb 15; 9(2):802-11. PubMed ID: 12576453
    [Abstract] [Full Text] [Related]

  • 17. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.
    Panelli MC, Wang E, Marincola FM.
    Clin Cancer Res; 2005 May 15; 11(10):3601-3. PubMed ID: 15897553
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
    Lamers CH, Sleijfer S, Vulto AG, Kruit WH, Kliffen M, Debets R, Gratama JW, Stoter G, Oosterwijk E.
    J Clin Oncol; 2006 May 01; 24(13):e20-2. PubMed ID: 16648493
    [No Abstract] [Full Text] [Related]

  • 20. CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours.
    Li G, Feng G, Cuilleron M, Zhao A, Gentil-Perret A, Cottier M, Genin C, Tostain J.
    Histopathology; 2009 Jun 01; 54(7):880-4. PubMed ID: 19469910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.